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Abstract
Obesity is a serious international health problem that increases the risk of several common diseases.
The genetic factors predisposing to obesity are poorly understood. A genome-wide search for type
2 diabetes–susceptibility genes identified a common variant in the FTO (fat mass and obesity
associated) gene that predisposes to diabetes through an effect on body mass index (BMI). An additive
association of the variant with BMI was replicated in 13 cohorts with 38,759 participants. The 16%
of adults who are homozygous for the risk allele weighed about 3 kilograms more and had 1.67-fold
increased odds of obesity when compared with those not inheriting a risk allele. This association was
observed from age 7 years upward and reflects a specific increase in fat mass.
Obesity is a major cause of morbidity and mortality, associated with an increased risk of type
2 diabetes mellitus, heart disease, metabolic syndrome, hypertension, stroke, and certain forms
of cancer. It is typically measured clinically with the surrogate measure of body mass index
(BMI), calculated as weight divided by height squared. Individuals with a BMI ≥ 25 kg/m2 are
classified as overweight, and those with a BMI ≥ 30 kg/m2 are considered obese. The
prevalence of obesity is increasing worldwide, probably as the result of changed lifestyle. In
2003–2004, 66% of the U.S. population had a BMI ≥ 25 kg/m2, and 32% were obese (1).
Twin and adoption studies have demonstrated that genetic factors play an important role in
influencing which individuals within a population are most likely to develop obesity in
response to a particular environment (2). However, despite considerable efforts, there are, as
yet, no examples of common genetic variants for which there is widely replicated evidence of
association with obesity in the general population. Monogenic forms of obesity at present
account for ∼7% of children with severe, young-onset obesity (3), but as this severity of obesity
is only seen in <0.01% of the population, these mutations are rare in the general population.
Recent attempts to identify gene variants predisposing to common, polygenic obesity have
proven controversial. Initial reports of promising associations between common variants in the
GAD2 (4–7), ENPP1 (5,8,9) and INSIG2 (9–12) genes and altered BMI have not been widely
replicated.
Obesity is a major risk factor for type 2 diabetes, and variants that influence the development
of obesity may also predispose to type 2 diabetes. As part of the Wellcome Trust Case Control
Consortium (WTCCC), we recently completed a genome-wide association study comparing
1924 U.K. type 2 diabetes patients and 2938 U.K. population controls for 490,032 autosomal
single-nucleotide polymorphisms (SNPs) (Wellcome Trust Case Control Consortium). SNPs
in the FTO (fat mass and obesity associated) gene region on chromosome 16 were strongly
associated with type 2 diabetes (e.g., rs9939609, OR = 1.27; 95% CI = 1.16 to 1.37; P = 5 ×
10−8). This association was replicated by analyzing SNP rs9939609 in a further 3757 type 2
diabetes cases and 5346 controls (OR = 1.15; 95% CI = 1.09 to 1.23; P = 9 × 10−6). Analysis
of BMI as a continuous trait was possible in the initial diabetes cases and in all replication
samples but not in the initial control samples. The diabetes-risk alleles at FTO were strongly
associated with increased BMI (Table 1). In the replication samples, the association between
FTO SNPs and type 2 diabetes was abolished by adjustment for BMI (OR = 1.03; 95% CI =
0.96 to 1.10; P = 0.44), which suggests that the association of these SNPs with T2D risk is
mediated through BMI. The major signal for association with BMI coincides perfectly with
that for type 2 diabetes, and rs9939609 represents a cluster of 10 SNPs in the first intron of
FTO that are associated with both traits (Fig. 1). All BMI-associated SNPs (P ranging from 1
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× 10−4 to 1 × 10−5) are highly correlated with each other (r2 from 0.52 to 1.0). SNP rs9939609
was used in all further studies, because among the cluster of most highly associated SNPs it
had the highest genotyping success rate (100%). The HapMap (haplotype map of the human
genome) population frequencies of the rs9939609 A allele are 0.45 in the CEPH (Centre d'Etude
du Polymorphisme Humain) Europeans, 0.52 in Yorubans, and 0.14 in Chinese and Japanese.
We studied the association of FTO gene variation with BMI and the risk of being overweight
and obese in an additional 19,424 white European adults from seven general population-based
studies (mean age 28 to 74 years, mean BMI 22.7 to 27.2 kg/m2) and in 10,172 white European
children from two studies (mean age 7 to 14 years, mean BMI 16.1 to 19.2 kg/m2) [table S1
and supporting online text (13)].
In all adult population-based studies, we found that the type 2 diabetes–associated A allele of
rs9939609 (frequency 39%) was associated with increased BMI (Table 1) with a median per-
allele change of ∼0.36 kg/m2 (range 0.34 to 0.46 kg/m2). In each study, carriers of two A alleles
had a higher BMI than heterozygote individuals; when we compared the additive model to a
general model in each study, there was no consistent evidence for departure from an additive
model. Because there was no evidence of heterogeneity (I2 = 0%) across the adult studies
(14), we combined them using the inverse variance method to pool continuous data (Z scores)
and the Mantel-Haenszel method for binary data. Each additional copy of the rs9939609 A
allele was associated with a BMI increase of a mean of 0.10 Z-score units (95% CI = 0.08 to
0.12; P = 2 × 10−20), equivalent to ∼0.4 kg/m2. When these data were combined with those
from the case-control samples (a total of 30,081 participants), the statistical confidence of the
association was further increased (P = 3 × 10−35) (Table 1 and fig. S1). When we applied a
Bonferroni correction for the number of tests performed in the initial genome-wide scan
(∼400,000), the association remained significant (P = 1.2 × 10−29). This association was present
in adults of all ages (Table 1) and of both sexes (fig. S1B and S1C), with no difference between
males and females (P = 0.13).
Although BMI is a continuous trait, standard cut-offs are used to assess the burden of increased
body weight on health. Hence, we assessed whether the inheritance of the FTO SNP rs9939609
altered the risk of being either overweight or obese compared with being normal weight (<25
kg/m2). In all the studies, the A allele was associated with increased odds of being overweight
(Fig. 2A) and also of being obese (Fig. 2B and table S2). In a meta-analysis of the population-
based studies, the per-A allele odds ratio (OR) for obesity in the adult general population was
1.31 (95% CI = 1.23 to 1.39; P = 6 × 10−16); for overweight, it was 1.18 (95% CI = 1.13 to
1.24; P = 1 × 10−12). When participants from the type 2 diabetes case and control studies were
included, the magnitude of the association was unchanged, although the statistical confidence
increased (obesity: OR = 1.32; 95% CI 1.26 to 1.39; P = 3 × 10−26; overweight: OR = 1.18;
95% CI = 1.14 to 1.23], P = 2 × 10−17). Individuals homozygous for the A allele at rs9939609
(16% of the population) are at substantially increased risk of being overweight (OR = 1.38;
95% CI = 1.26 to 1.52]; P = 4 × 10−11) or obese (OR = 1.67; 95% CI = 1.47 to 1.89; P = 1 ×
10−14) compared with those homozygous for the low-risk T allele (37% of the population).
The extent of the variance in BMI explained by rs9939609 was ∼1%, and the population
attributable risk was 20.4% for obesity and 12.7% for overweight.
Childhood obesity is also increasing rapidly worldwide and is a cause of considerable concern
(15). To determine the age at which the association of FTO SNP rs9939609 with BMI first
becomes evident, we analyzed two large birth cohorts for which suitable measures were
available from birth to early adolescence. These included 7477 UK children from the Avon
Longitudinal Study of Parents and Children (ALSPAC) cohort who had anthropometric
measures at birth and at 7, 8, 9, 10, and 11 years of age and 4320 children from the Northern
Finland 1966 birth cohort (NFBC1966) with birth measures as well as height and weight
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available at 14 years. rs9939609 was not associated with birth weight (Table 2) or ponderal
index at birth (table S3A) in either cohort. In children from the ALSPAC study, each copy of
the rs9939609 A allele was associated with an increase in BMI by 0.08 Z-score units (95% CI
= 0.04 to 0.12; P = 3 × 10−5; ∼0.2 kg/m2) at age 7, an association maintained up to the most
recent assessment at age 11, when the per-allele increase was 0.12 Z-score units (95% CI =
0.08 to 0.16; P = 7 × 10−9; ∼0.4 kg/m2) (Table 2). At all ages, the A allele was associated with
an increased risk of childhood obesity (e.g., OR per-A allele at age 11 years = 1.35; CI = 1.14,
1.61; P = 6 × 10−4) and of being overweight (e.g., OR per-A allele at age 11 years = 1.27; CI
= 1.16 to 1.39; P= 2 × 10−7), as defined by age-specific BMI (table S2). In the Finnish cohort,
each copy of the rs9939609 A allele was associated with an increase in BMI by 0.05 Z-score
units (95% CI = 0.003 to 0.09; P = 0.04; ∼0.1 kg/m2) at the age of 14 years (Table 2). We
conclude therefore that FTO SNP rs9939609 is not associated with changes in fetal growth but
is associated with changes in BMI and obesity in children by the age of 7, changes that persist
into the prepubertal period and beyond.
BMI is a convenient surrogate measure for obesity, but it may be influenced by changes in
height, bone mass, and lean mass, as well as adiposity. We used additional anthropometric
measurements available in the study samples to address this issue. In all population-based
cohorts, the rs9939609 A allele was associated with higher weight (overall per-A allele increase
= 0.09 Z-score units; 95% CI = 0.07 to 0.11); P = 4 × 10−17; ∼1.2 kg in adults) (tables S3B
and S3C), but there was no difference in height (tables S3C and S3D). Consistent with this
observation, we found evidence for higher waist circumference (overall per-A allele = 0.08 Z-
score units; 95% CI = 0.05 to 0.11; P = 4 × 10−9; ∼1 cm) (table S3E) and higher subcutaneous
mass assessed by skinfold measures (per-A allele difference = 0.11 Z-score units; 95% CI =
0.06 to 0.16; P = 2 × 10−5) (table S3F). In the children from the ALSPAC study, dual-energy
x-ray absorptiometry (DEXA)–derived measures of fat mass and lean mass were available at
age 9. The association of rs9939609 A allele with weight was almost exclusively attributable
to changes in fat mass, with a per-allele difference of 0.12 Z-score units (95% CI = 0.08 to
0.16; P = 6 × 10−10), equivalent to a 14% difference across the three genotype groups) (Fig.
2C). Genotype-related differences in lean mass were, in contrast, a modest 0.04 Z-score units
(95% CI = 0.005 to 0.08; P = 0.03), which is equivalent to a 1% increase across the three
genotype groups) (Fig. 2D). Therefore, the association of genetic variation at FTO with BMI
results from longitudinal changes in fat mass that, on the basis of anthropometric measures,
reflect both increased waist circumference and subcutaneous fat.
One important potential source of false-positive associations in genetic studies is population
stratification. We do not believe this is likely to be important in the association of the FTO
SNP with BMI or type 2 diabetes. In all study cohorts, any individuals who were not European
whites were excluded. In addition the cohorts were all recruited from single countries, with the
majority coming from specific small geographically defined regions, and the analysis for
association was done only within individual cohorts. Analysis of the FTO signal does not
support this association resulting from population stratification. In the original genome-wide
association study, the principal component analysis (16) implemented in EIGENSTRAT (17)
made no difference to the evidence for association for type 2 diabetes (P = 5.3 × 10−8 with
EIGENSTRAT adjustment and 5.2 × 10−8 without). Similarly, adjusting for the 11 geographic
regions did not alter the significance of the FTO association for BMI (P = 9 × 10−6 adjusted;
8 × 10−6 unadjusted). The minor allele frequency of rs9939609 differs very little across our
studies from Finland, Italy, and many different regions in the UK ranging from 0.38 to 0.40 in
all except the second-smallest study, where it was 0.44. We found no significant regional
variation in allele frequency in UK type 2 diabetic patients, whether testing 4 (P = 0.41) or 11
(P = 0.22) geographical regions of residence. For all these reasons, we do not believe that
stratification/structure effects provide a realistic interpretation of our findings.
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We have shown that common variation in the FTO gene is reproducibly associated with BMI
and obesity from childhood into old age. SNP rs9939609 lies within the first intron of the
FTO gene and, based on information from HapMap, is highly correlated (r2 > 0.5), with 45
additional SNPs within a 47-kb region that encompasses parts of the first two introns as well
as exon 2 of FTO. There are no features to suggest that any of these SNPs represents the
functional variant. Linkage disequilibrium between the BMI-associated SNPs and other
variants falls rapidly outside the 47-kb region, such that there are no SNPs correlated at r2 >
0.2 outside a 90-kb interval (Fig. 1 and fig. S2). Sequencing of 47 individuals selected for BMI
> 40 kg/m2 has revealed no clear candidate functional variants in the FTO coding region and
minimal splice sites or 3′ UTR to explain the association (table S4). FTO is closely adjacent
to a gene of unknown function KIAA1005 (Fig. 1 and fig. S2), which is transcribed in the
opposite direction. This opens up the possibility that genetic variation affects a regulatory
element for KIAA1005; however, there is no obvious such variant within the 47-kb associated
region. We conclude that the 47-kb intron within the FTO gene is most likely to contain the
predisposing variant(s), but there is, at present, no clear genetic mechanism to explain how this
alters the function or expression of FTO, KIAA1005, or more distant genes.
FTO is a gene of unknown function in an unknown pathway that was originally cloned as a
result of the identification of a fused-toe (Ft) mutant mouse that results from a 1.6-Mb deletion
of mouse chromosome 8 (18). Three genes of unknown function (Fts, Ftm and Fto), along with
three members of the Iroquois gene family (Irx3, Irx5, and Irx6 from the IrxB gene cluster),
are deleted in Ft mice (18). The homozygous Ft mouse is embryonically lethal and shows
abnormal development, including left/right asymmetry (19). Heterozygous animals survive
and are characterized by fused toes on the forelimbs and thymic hyperplasia but have not been
reported to have altered body weight or adiposity (19). The fused-toe mutant is a poor model
for studying the role of altered Fto activity, because multiple genes are deleted. Neither isolated
inactivation nor overexpression of Fto has been described.
We used reverse transcription PCR to assess the expression of FTO and KIAA1005 in a human
tissue panel (18). FTO was found to be widely expressed in fetal and adult tissues, with
expression highest in the brain (fig. S3A). The transcription start site of KIAA1005 lies only
200 base pairs from the 5′ end of FTO and ∼61 kb from the 47-kb interval containing the BMI
associations. KIAA1005 is also ubiquitously expressed with relatively high levels in
hypothalamus and islet (fig. S3B). The similarity of expression profile between these two
transcripts may indicate joint transcriptional regulation but does not provide insights into which
of the two genes is more likely to be involved. Further work with both knockout and
overexpression models of FTO and KIAA1005 are likely to provide the most fruitful approach
to understanding the mechanism and pathways whereby these variants influence the risk of
obesity.
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Fig. 1.
Associations of SNPs in the FTO/KIA1005 region of chromosome 16 with (A) type 2 diabetes
using 1924 cases and 2938 controls and (B) adult BMI in type 2 diabetic patients. (C) Linkage
disequilibrium (r2) between associated SNP rs9939609 and all other SNPs in HapMap data in
Caucasian European samples. (D) Gene positions.
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Fig. 2.
(A and B) Meta-analysis plots for odds of (A) overweight and (B) obesity, compared with
normal weight in adults for each copy of the A allele of rs9939609 carried. (C and D) Bar
charts showing (C) DEXA-measured fat mass in 9-year-old children and (D) DEXA-measured
lean mass in 9-year-old children, both from the ALSPAC study. Error bars represent 95%
confidence intervals
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